
-
2015 February 01
Company Description
App enabling drug safety and interactions across 54m products and manufacturers, with a DNA Test for disease for pre dispositions
The Molecular Life solution offering consists of Apps, Web Portals and a DNA Test. Users can store personally selected information about their health profile, link it with drug knowledge from recognized published sources, and by taking a DNA test, cross-reference their profile with genomic statistics from across the world. The app can be available as a health tool without the DNA based information, with the app white-labeled for insurance, health, hospital and travel related businesses, providing businesses with marketing eco-systems offering customer engagement, loyalty and retention. With our value proposition being in the health and well being space (both B2B and B2C) the app is a 'challenger' for health knowledge and drug safety, as well drug drug interactions (including severity) The app has: Products 97,331 Ingredients 9,136 Ingredients linked to product 1,051,316 Product Ingredient interactions 4,691,343 Product label records 889,605 Product synonyms 54,026,066 The DNA Test can identify known associations or potential issues linked to their genomic profile, around drug interactions and disease predispositions. The DNA SNP that Molecular Life are using was designed by Molecular Life and Affymetrix and is across 850,000 data points and 2,300 genes
-
Manufacturer:
Financial Services -
Formed:
February 1, 2015 -
Company Website:
-
Company E-mail:
-
Company Address:
1 Fore StreetUnited KingdomLondon -
CEO:
- John Ireland
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits